• No results found

Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial

N/A
N/A
Protected

Academic year: 2022

Share "Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial"

Copied!
7
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Methods Patient-reported sleep was a predefined secondary outcome in a prospective, randomized, placebo-controlled, double- blind trial that evaluated the analgesic efficacy

Two randomized, double-blind, placebo-controlled, cross-over trials have shown sumatriptan 6 mg sc to be a rapid, effective and well-tolerated acute treatment for cluster

The aim of the present study was to explore whether actigraphy could be used as a tool to register symptoms during alcohol detoxification, whether oxytocin affected actigraphy

A double-blinded, randomized, placebo- controlled trial to evaluate efficacy, safety and tolerability of single doses of tirasemtiv in patients with acetylcholine receptor

To improve the clinical evidence on long-term effect for patients with CEH, we per- formed a randomized, controlled study which compared occipital cryoneurolysis with injections of

Consequently, the aim of the present study was to investigate the effect of pain treatment on sleep in NH patients with dementia and depression in a placebo ‐ controlled

Faecal microbiota transplantation versus placebo for moderate- to- severe irritable bowel syndrome: a double- blind, randomised, placebo- controlled, parallel- group, single-

Figure 2 Change in the pain treatment and control groups in the mood syndrome factor group (depression, anxiety, apathy, irritability, night-time behaviours and appetite and